Also, increased Cx43 and reduced Cx47 immunoreactivity were observed at the progressive and end stages of an amyotrophic lateral sclerosis mouse model (Cui et al., 2014). This evidence concerns the gene GJC2 and amyotrophic lateral sclerosis.